It's not the altitude, it's the attitude.
ABOUT US
Scott Fischer (Everest)
OUR STORY
Launched in 2023, Release Tx is driven by a deep legacy in allogeneic encapsulated cell therapy. United by a commitment to treat and reverse genetic brain disorders without the risks associated with altering a patient’s genes, our team has been instrumental in advancing this technology from early research to a transformative solution for disorders of the CNS.
OUR VISION
Our vision is to treat genetic disorders of the CNS without gene therapy. →Find out why
OUR MISSION
Our mission is to get therapeutic proteins where they are needed most, in the CNS and beyond.

Leadership Team
OUR

Read More >
Julien Grogg, PhD, MBA

Read More >
Professor Nicolas Mach
Team
OUR

Salina Arope, PhD

Adrien Engel, Ph.D, PMP®
Partners
OUR

Read More >
Françoise Piguet, PhD

Read More >
Françoise Piguet, PhD
Scientific Advisors
OUR

Read More >
Caroline Sevin, MD, PhD

Read More >
Timothée de St. Denis, MD, PhD

Read More >
Bernard Schneider, PhD

Read More >
Aurélien Lathuilière, MD, PhD

Read More >
Professor Mikael Pittet

Read More >
Professor Pedro Romero
Board of Directors
OUR

Ksenija Pavletic — Member

Clarence Peter — Chairman

Professor Nicolas Mach — Member

Feisal Abukscem, PhD — Member